INGN Q2 2017 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$172M

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$64M+17.5% YoY

Gross Profit

$32M49.2% margin

Operating Income

$8M13.3% margin

Net Income

$8M13.0% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

+22.1%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$16M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$251M

Total Liabilities

$43M

Stockholders' Equity

$208M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$55M	+17.5%
Gross Profit	$32M	$26M	+20.4%
Operating Income	$8M	$8M	+6.0%
Net Income	$8M	$5M	+62.2%

Geographic Segments

UNITED STATES

$49M77%

Non Us

$15M23%